Scientific Presentations

Explore our Exhibitor-Hosted Session from SOT & ToxExpo 2025 to learn about a novel microphysiological model designed to mimic the gut-hepatic barrier.

View our SLAS 2025 presentation to learn about the application of ThawReady™ cells in EV-mediated repair assays and HIV-1 infection assays.

View our Exhibitor Hosted Session from ACT 2024 to learn about ATCC's immortalized primary cells and their applications in toxicology.

This presentation from BioProcess International 2024 showcases how ATCC is advancing QC reference materials through cryobiology.

View this presentation from the 2024 Nanopore Community Meeting to learn how ATCC's collection offers unparalleled insight into Nanopore sequencing efficiency.

Download our plenary session from CRYO 2024 to learn how we are advancing the future of cell models.

View our CRYO 2024 presentation to learn about the application of our ThawReady™ cells.

View our presentation from CRYO 2024 to see how lyophilization formulations can affect bacterial viability and genetic variability.

Check out our presentation from CRYO 2024 to learn how standardized cryoprotective additives can improve fungal preservation.

In this ASM Microbe 2024 Industry & Science Showcase, discover how ATCC is meeting the challenges researchers face when using quantified reference materials, and learn how Cultivarium is combining the power of ATCC microbial strains and next-generation technology to unlock the genetic potential of the biosphere.

This is a presentation from ASM Microbe 2024 that showcases RAISIN—a simple, fast, and accurate variant annotation pipeline.

Check out our 2023 AMP Corporate Workshop to learn how ATCC supports each stage of the assay development workflow with authenticated cell models, microbial strains, and derivatives that are backed by whole-genome sequencing data and bioinformatics analyses.

In this study presented at CRYO 2023, ATCC scientists evaluated the impact of low-temperature storage on the functionality and growth characteristics of luciferase reporter cells.

This Industry & Science Showcase from ASM Microbe 2023 showcases the development of ATCC NGS Standards and their applications in microbiome analyses.

In this workshop, we highlighted how state-of-the-art ATCC drug-resistant cancer cell models created by CRISPR gene-editing technology can facilitate the discovery of new types of therapeutics that overcomes drug resistance.

In this workshop presentation, we discuss the importance of credible reference materials in microbial genomics with a particular focus on microbiome and phylogenetic studies. We also preview ATCC’s genome portal of high-quality assembled genomes for advancing the authentication of ATCC strains.

ATCC molecular signature panels focus on key components of cell signaling pathways such as EGFR, AKT, PI3K, PTEN, or p53. This presentation describes how we generated these panels using authenticated cell lines containing critical gene copy number changes and site mutations.

In this collaborative discussion, microbiome experts discuss the hurdles that microbiome researchers face during each stage of the workflow, challenges and solutions in the development and application of standards, and current gaps and future trends in microbiome research.

The use of unauthenticated biological reference materials, lack of source metadata, and frequent gaps in data provenance have mounted concerns about the reliability and reproducibility of preclinical research data. In this presentation, we showcase our efforts to overcome this problem through characterization of the whole transcriptomes of human and animal cell models.

Watch the presentation to learn more about the importance of data provenance in genomics and ATCC’s approach to producing high-quality, authenticated reference genomes.

This workshop highlighted two application areas of our current focus: 2-D and 3-D models for the Human Cancer Models Initiative (HCMI) and reporter models and primary cells for immuno-oncology–based therapeutics. Download the presentation to learn about organoids, neurospheres, conditionally reprogrammed cells, CAR-T Target reporters for assessing effector cell potency, checkpoint inhibitor reporters, and primary CD8+ cytotoxic T cells.

In this presentation, we explore the development of fungal NGS standards for mycobiome research and demonstrate the utility of these standards in evaluating DNA extraction and sequencing methods for mycobiome analysis.

Mutations in several of the enzymes in the PI3K pathway have been implicated in the pathogenesis of several types of cancer. In this presentation, we discuss the development and application of several cell panels comprising tumor cell lines that feature mutations along the PI3K pathway.

Check out our AMP 2022 Corporate Workshop to learn more about our standardized approach to producing high-quality reference genomes from authenticated ATCC biological materials.

ATCC Human telomerase (hTERT) immortalized cell lines combine the in vivo nature of primary cells and the long culture life of continuous cell lines. This presentation provides an overview of the hTERT-immortalized cell line collection at ATCC.

ATCC has a wide selection of induced pluripotent and mesenchymal stem cells along with an array of associated culture media and reagents. This presentation provides an overview of the ATCC stem cell collection and describe how these resources can be used in cell biology studies.

This is a talk presented at the American Exosome and RNA Conference that demonstrates a method for the isolation of high-quality EVs from large-scale batches.

The complexities involved in metagenomics methods often result in the introduction of biases throughout the workflow, ultimately impacting data interpretation and reproducibility. This workshop highlights the importance of standards in facilitating assay standardization and optimization in microbiome research.

One of the primary obstacles in standardizing metagenomics assays in microbiome research is the limited availability of reference materials and robust analytical tools. In this workshop, we discuss the development of mock microbial communities and explore their application as NGS standards in microbiome research.

Developing cell-based assays can be problematic; the cells must be physiologically relevant for the assay to be predictive, yet sufficiently abundant to be included in the assay without introducing interexperimental variability. In this presentation, ATCC experts discussed the characteristics and utility of various respiratory, skin, and kidney models in toxicological assays.

In this presentation, Dr. Clinton provided an overview of the Human Cancer Models Initiative (HCMI) and the technologies driving the development of next-generation models.

See our presentation presentation to learn about the characteristics of respiratory, ocular, cardiovascular, skin, reproductive, and kidney hTERT-immortalized primary cells, and their versatile utility in toxicological assays.

In this presentation, Dr. Riojas will briefly describe who ATCC and BEI Resources are and will detail our responses to recent infectious disease threats.

This presentation highlights the importance of the authenticity and traceability of genomic data and details ATCC's approach to whole-genome sequencing, assembly, and genome annotation for producing high-quality, authenticated reference genomes.

In this presentation, Dr. Knight-Connoni will discuss the diversity of the ATCC mycology collection and the application of these strains in bioremediation.

This presentation examines the use of ATCC materials in molecular-based assays for cancer detection and analysis and assay development for infectious diseases.

This presentation highlights the importance of genomics data provenance and details how the ATCC Genome Portal addresses this issue.

ATCC offers a superior lipid-based transfection reagent (TransfeX) that can be used to transfect difficult cell types, like primary and stem cells, and uncomplicated continuous cell lines. In this presentation, we show how TransfeX provides higher transfection efficiency and lower cytotoxicity than other commercially available transfection reagents.